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The goals of the different phases of 
the Human Genome Project 
(1) determine the linkage map of the 
human genome  
(2) construct a physical map of the genome 
by means of cloning all fragments and 
arrange them in the correct order  
(3) determine the nucleotide sequence of 
the genome 
(4) provide an initial exploration of the 
variation among human genomes. 
 As of October 2004 about 93% of the human genome (which corresponds 
to 99% of the euchromatic portion of the genome) had been sequenced to 
an accuracy of better than one error in 100,000 nucleotides. 
 The length of the human chromosomes ranges from ~46 Mb to ~247 Mb. 
 The average GC content of the human genome is 41%. 
 This varies considerably among the different chromosomes and within the 
different bands of each chromosome. Chromosomal bands positive for 
Giemsa staining have lower average GC content of 37%, while in Giemsa-
negative bands the average GC content is 45%. Interestingly, Giemsa-
negative bands are gene rich regions of DNA.  


 The sequence of the human genome is 
freely and publicly available on the 






 There is now a considerable effort 
internationally to identify all the functional 
elements of the human genome.  
 A collaborative project called ENCODE 
(ENcyclopedia Of DNA Elements) is 
currently in progress with the ambitious 
objective to identify all functional 
elements of the human genome 
 The current classification of the functional 
elements of the genome contains: 
 1. Protein-coding genes 
 2. Noncoding, RNA-only genes 
 3. Regions of transcription regulation 
 4. Conserved elements not included in the 
above categories 
CCDS 
 The so-called CCDS set ( consensus coding sequence) is built by consensus among the 
European Bioinformatics Institute (http://www.ebi.ac.uk/), the National Center for 
Biotechnology Information (http:// www.ncbi.nlm.nih.gov/), the Wellcome Trust 
Sanger Institute (http://www.sanger.ac.uk/), and the University of California, Santa 
Cruz (UCSC; http://www.cbse. ucsc.edu/). At the last update (5 July 2009; genome 
build 36.3) CCDS contains 17,052 genes. This is the minimum set of protein-coding 
genes included in all genomic databases. The reference sequence (RefSeq) collection 
of genes of the NCBI contains 20,366 protein- coding gene entries 
(http://www.ncbi.nlm.nih.gov/RefSeq/); the UCSC collection of genes contains 
23,008 entries http://genome.ucsc.edu/);  the Ensembl browser contains 21,416 
entries (23 June 2009; build 36; http://www.ensembl.org/Homo_sapiens/Info/ Stats 
Table). The total number of annotated exons listed in the Ensembl database is 
297,252 (23 June 2009; build 36). The discrepancy among the databases reflects the 
ongoing and unfinished annotation of the genome. 
The different classes of RNA-only 
genes 
1. rRNAs 
 Ribosomal RNA (rRNA) Genes: ~650–900. These are genes organized in tandemly 
arranged clusters in the short arms of the five acrocentric chromosomes (13, 14, 
15, 21, and 22). The transcripts for 28 S, 5.8 S, and 18 S rRNAs are included in 
one transcription unit, repeated 30–50 times per chromosome. These tandemly 
arranged genes are continuously subjected to concerted evolution, which results 
in homogeneous sequences due to unequal homologous exchanges. The 
transcripts for the 5 S rRNAs are also tandemly arranged, and the majority map 
to chromosome 1qter. 
 
2. tRNAs 
 Transfer RNA (tRNA) : ~500 (49 Types).  
 At the last count there are 497 transfer RNA 
genes (usually 74–95 nucleotides long) encoded 
by the nucleus and transcribed by RNA 
polymerase III (additional tRNAs are encoded by 
the mitochondria genome). There are also 324 
tRNA pseudogenes . The tRNA nuclear genes 
form 49 groups for the 61 different sense codons. 
 Although the tRNA genes are dispersed 
throughout the genome, more than 50% of these 
map to either chromosomes 1 or 6; remarkably 
25% of tRNAs map to a 4-Mb region of 
chromosome 6. 
3.snRNAs 
 Small Nuclear RNA (snRNA): ~100. 
 These are heterogeneous small RNAs.  A 
notable fraction of these are the 
spliceosome RNA genes many of which are 
uridine-rich; the U1 group contains 16 genes, 
while U2 contains six, U4 4, U6 44, and the 
other subclasses are represented by one 
member. Some of these genes are clustered, 
and there is also a large number of 
pseudogenes (more than 100 for the U6 
class). 
4. snoRNAs 
 Small Nucleolar RNA (snoRNA) : ~200.  
 This is a large class of RNA genes that process and modify the 
tRNAs and snRNAs .  
 There are two main families: 
 C/D box snoRNAs that are involved in specific methylations 
of other RNAs; and H/ACA snoRNAs, mostly involved in 
site-specific pseudouridylations. Initially, there were 69 
recognized in the first family and 15 in the second ; however, 
the total number is probably larger. 
 A cluster of snoRNAs maps to chromosome 15q in the 
Prader–Willi syndrome region (at least 80 copies); deletions 
of which are involved in the pathogenesis of this syndrome.  
Another cluster of snoRNAs maps to chromosome 14q32 
(~40 copies).  
 The majority of snoRNAs map to introns of protein-coding 
genes and can be transcribed by RNA polymerase II or III. 
5. miRNAs 
 Micro RNAs (miRNA) : (706 Entries on 26 June 2009).  
 These are single-stranded RNA molecules of about 21–23 nt 
in length that regulate the expression of other genes.  
 miRNAs are encoded by RNA genes that are transcribed 
from DNA but not translated into protein; instead they are 
processed from primary transcripts known as pri-miRNA to 
short stem-loop structures called pre-miRNA and fi nally to 
functional miRNA. Mature miRNA molecules are 
complementary to regions in one or more messenger RNA 
(mRNA) molecules, which they target for degradation. A 
database of the known and putative miRNAs, and their 
potential targets, can be found in 
http://microrna.sanger.ac.uk/. miRNAs have been shown to 
be involved in human disorders. 
6. LincRNAs 
 Large Intervening Noncoding RNAs (LincRNAs) : ~1,600.  
 This new class has been recently identified using 
trimethylation of Lys4 of histone H3 as a genomic mark to 
observe RNA PolII transcripts at their promoter, and 
trimethylation of Lys36 of histone H3 marks along the length 
of the transcribed region to identify the spectrum of PolII 
transcripts. Approximately 1,600 such LincRNA transcripts 
have been found across four mouse cell types (embryonic 
stem cells, embryonic fibroblasts, lung fibroblasts, and neural 
precursor cells).  
 Among the “exons” of these LincRNAs, approximately half 
are conserved in mammalian genomes, and are thus present 
in human. Since this class was described in 2009, further 
work is needed for its characterization and validation, as well 
as the potential overlap of its members with the other 
classes. 
7. Other Noncoding RNAs 
 Other Noncoding RNAs: ~1,500.  
 The field of noncoding RNA series is constantly 
expanding. Some of these RNA genes include 
molecules with known function such as the 
telomerase RNA, the 7SL signal recognition 
particle RNA, and the XIST long transcript 
involved on the X-inactivation.  
 There are also numerous antisense noncoding 
RNAs, and the current effort to annotate the 
genome suggests that a substantial fraction of the 
transcripts are noncoding RNAs. 

Mitochondrial Genome 
 In human cells there is also the mitochondrial genome, which is 16,568 nucleotides long and 
encodes for 13 protein-coding genes, 22 tRNAs, one 23 S rRNA, and one 16 S rRNA 
(http://www.mitomap.org). 
 The mitochondria genome-encoded genes are all essential for oxidative phosphorylation and 
energy generation in the cell. Each cell has hundreds of mitochondria and thousands (103 –104 
) of mitochondria DNA (mtDNA) copies. Human mtDNA has a mutation rate ~20 times 
higher than nuclear DNA. The inheritance of mtDNA is exclusively maternal (the oocyte 
contains 10 5 mtDNA copies). Several human phenotypes are due to pathogenic mutations in 
the mitochondrial genome. 
Genomic Variability 
1. Single Nucleotide Polymorphisms 
 The majority of the DNA variants are single 
nucleotide substitutions commonly known as 
SNPs (single nucleotide polymorphisms). The first 
SNPs were identified in 1978 in the laboratory of 
Y.W. Kan 3’ to the β–globin Gene. 
 
 There is on average one SNP in ~1,000 nucleotides between two 
randomly chosen chromosomes in the population. Many of these SNPs are 
quite common.  A common SNP is that in which the minor allele frequency 
(MAF) is more than 5%. On average two haploid genomes differ in 
~3,000,000 SNPs. 
 In addition, there is a large number of rare (MAF < 1%) or near-rare (MAF 
between 1% and 5%) SNP variants that could be identified by the genome 
sequencing of various individuals. The majority of heterozygous SNPs in the 
DNA of a given individual are relatively common in the population; on the 
other hand, most of the SNPs discovered in a population are more likely to 
be rare. The NCBI SNP database contains 25 million common and rare 
SNPs (http://www.ncbi.nlm.nih.gov/SNP/snp_summary.cgi; version 130; July 
2009).  
 Of those, ~301,000 are in the protein-coding regions of genes, and 
~188,000 result in amino acid substitutions (nonsynonymous 
substitutions).  An international project known as HapMap 
(http://www.hapmap.org/) has completed the genotyping of ~4,000,000 
common SNPs in individuals of different geo-ethnic origins (4,030,774 
SNPs in 140 Europeans; 3,984,356 in 60 Yoruba Africans; 4,052,423 in 45 
Japanese and 45 Chinese; http://www.hapmap. 
org/downloads/index.html.en).  
2. Short Sequence Repeats 
 Short sequence repeats (SSRs) are polymorphic variations due 
to a different number of short sequence repeat units, first 
described by Wyman and White (then called VNTRs, variable 
number of tandem repeats 
3. Insertion/Deletion Polymorphisms 
(Indels) 
4. Copy Number Variants (CNVs) 
5. Inersions 
 An example of a common inversion polymorphism involves a 900-
kb segment of chromosome 17q21.31, which is present in 20% of 
European alleles but it is almost absent or very rare in other 
populations. These variants are difficult to identify and most of 
them have been detected by sequencing the ends of specific DNA 
fragments and comparing them with the reference sequence 
6. Mixed Polymorphisms 
Genome Variation as a Laboratory 
Tool to Understand the Genome 
 1. Create linkage (genetic) maps of human chromosomes. This has allowed the initial mapping of 
the human genome and it was a prerequisite for the sequence assembly. 
 2. Map the genomic location of monogenic phenotypes to human chromosomes by linkage 
analysis. A large number of such phenotypes have been mapped to small genomic intervals 
because of the genotyping of members of affected families. Positional cloning of pathogenic 
mutations was subsequently possible. 
 3. Map the genomic location of polygenic phenotypes to human chromosomes by genome wide 
linkage and association studies. 
 4. Allow fetal diagnosis and carrier testing by linkage analysis of the cosegregation of a 
polymorphic marker and the phenotype of interest. 
 5. Perform paternity and forensic studies. A whole field was developed mainly with the use 
microsatellite SSR variants. 
 6. Study genome evolution and origin of pathogenic mutations. 
 7. Study the recombination rate and properties of the human genome. 
 8. Study the instability of the genome in tumor tissues. 
 9. Identify loss-of-heterozygosity in human tumors. 
 10. Study uniparental disomy and thus help with understanding genomic imprinting. 
 11. Study parental and meiotic origin, and decipher the mechanisms of nondisjunction. 
 12. Study population history and substructure. 
